Corpus Intelligence IC Memo — CRISP REGIONAL HOSPITAL INC. 2026-04-26 14:15 UTC
IC Memo — CRISP REGIONAL HOSPITAL INC.
Investment Committee Memorandum | GA | 65 beds | Grade C | EBITDA uplift $8.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CRISP REGIONAL HOSPITAL INC.

CCN 110104 | CRISP, GA | 65 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CRISP REGIONAL HOSPITAL INC. is a 65-bed suburban community hospital in CRISP, GA with $115.2M in net patient revenue and a -8.7% operating margin. The hospital serves a payer mix of 20.1% Medicare, 10.0% Medicaid, and 69.9% commercial.

Thesis: Turnaround. Our ML models identify $8.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.7% to -1.4% (+736bps).

Net Revenue HCRIS$115.2M
Current EBITDA COMPUTED$-10.0M
Operating Margin COMPUTED-8.7%
Occupancy HCRIS54.9%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS34.7%
Distress Probability ML47.7%

2. Market Context & Competitive Position

165
GA Hospitals
-2.8%
State Median Margin
71
Comparable Hospitals

GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of -8.7% places it below the state median. Among 71 size-comparable peers (32-130 beds), the median margin is -1.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (32-130), prioritizing same-state peers. 71 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CRISP REGIONAL HOSPITAL INC. (Target)GA65$115.2M-8.7%
TANNER MEDICAL CENTER-VILLA RIGA58$289.8M33.3%
PAULDING MEDICAL CENTERGA112$288.5M9.0%
SHEPHERD CENTERGA130$254.9M-20.8%
DOUGLAS HOSPITALGA112$217.2M-0.8%
NORTHSIDE HOSPITAL - DULUTHGA87$193.2M-3.1%
ADVENTHEALTH GORDONGA69$188.5M-3.4%
COLQUITT REGIONAL MEDICAL CENTGA99$173.8M-17.0%
FAIRVIEW PARK HOSPITALGA122$169.8M21.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.4M+210bp18mo
Cost to Collect4.5%2.5%$2.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.4M+122bp9mo
Clean Claim Rate88.0%96.0%$74K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.4M
Cost to Collect
$2.3M
Denial Rate Reduction
$2.3M
A/R Days Reduction
$1.4M
Clean Claim Rate
$74K
Total EBITDA Uplift$8.5M
Current EBITDA$-10.0M
+ RCM Uplift+$8.5M
Pro Forma EBITDA$-1.6M
Current Margin-8.7%
Pro Forma Margin-1.4%
WC Released (1x)$4.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-15.5M$18.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-15.5M$15.3M0.00x-100.0%
Bull Case9.0x11.0x$-13.9M$38.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-13.9M$37.6M0.00x-100.0%
Bear Case11.0x10.0x$-17.0M$-18.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-17.0M$-26.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 71 hospitals with 32-130 beds
  • Same-state prioritization (n=72)
  • Comp margins: P25=-15.1% / P50=-1.4% / P75=7.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.